Profile | GDS4284 / 221078_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4335.71 | 92 |
GSM687648 | Patient 402 control | 4312.7 | 92 |
GSM687653 | Patient 403 control | 3524.08 | 90 |
GSM687658 | Patient 404 control | 2503.27 | 87 |
GSM687663 | Patient 411 control | 2949.69 | 89 |
GSM687668 | Patient 422 control | 3276.03 | 90 |
GSM687673 | Patient 424 control | 3059.61 | 89 |
GSM687678 | Patient 425 control | 2311 | 85 |
GSM687683 | Patient 427 control | 3766.08 | 91 |
GSM687688 | Patient 428 control | 1532.47 | 80 |
GSM687695 | Patient 441 control | 983.295 | 75 |
GSM687699 | Patient 443 control | 2565.32 | 87 |
GSM687704 | Patient 444 control | 3514.49 | 90 |
GSM687707 | Patient 448 control | 2603.05 | 87 |
GSM687712 | Patient 449 control | 3427.65 | 90 |
GSM687719 | Patient 450 control | 2276.09 | 86 |
GSM687724 | Patient 451 control | 1258.1 | 78 |
GSM687728 | Patient 452 control | 2197.11 | 85 |
GSM687646 | Patient 401 treated 24h | 5134.83 | 94 |
GSM687649 | Patient 402 treated 24h | 4884.4 | 93 |
GSM687665 | Patient 411 treated 24h | 2843.87 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 3820.35 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 3306.12 | 90 |
GSM687670 | Patient 422 treated 24h | 3500.66 | 90 |
GSM687671 | Patient 422 treated 4 weeks | 3708.37 | 91 |
GSM687654 | Patient 403 treated 24h | 3413.3 | 90 |
GSM687675 | Patient 424 treated 24h | 3550.67 | 91 |
GSM687685 | Patient 427 treated 24h | 3241.05 | 90 |
GSM687656 | Patient 403 treated 4 weeks | 3888.88 | 91 |
GSM687677 | Patient 424 treated 4 weeks | 2616.63 | 87 |
GSM687687 | Patient 427 treated 4 weeks | 5780.45 | 94 |
GSM687692 | Patient 428 treated 4h | 1894.53 | 83 |
GSM687716 | Patient 449 treated 4h | 2753.17 | 88 |
GSM687722 | Patient 450 treated 4h | 2474.02 | 87 |
GSM687680 | Patient 425 treated 24h | 2517.96 | 87 |
GSM687690 | Patient 428 treated 24h | 1967.52 | 84 |
GSM687700 | Patient 443 treated 24h | 1222.59 | 77 |
GSM687705 | Patient 444 treated 24h | 2366.38 | 86 |
GSM687714 | Patient 449 treated 24h | 3345.3 | 90 |
GSM687721 | Patient 450 treated 24h | 2175.03 | 85 |
GSM687682 | Patient 425 treated 4 weeks | 1941.88 | 83 |
GSM687694 | Patient 428 treated 4 weeks | 2015.78 | 84 |
GSM687702 | Patient 443 treated 4 weeks | 2467.49 | 87 |
GSM687718 | Patient 449 treated 4 weeks | 2377.71 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2448.67 | 86 |
GSM687661 | Patient 404 treated 4h | 2391.14 | 86 |
GSM687710 | Patient 448 treated 4h | 2796.18 | 88 |
GSM687726 | Patient 451 treated 4h | 1483.49 | 80 |
GSM687730 | Patient 452 treated 4h | 56.2591 | 13 |
GSM687660 | Patient 404 treated 24h | 945.564 | 75 |
GSM687697 | Patient 441 treated 24h | 865.425 | 72 |
GSM687709 | Patient 448 treated 24h | 2878.36 | 88 |
GSM687725 | Patient 451 treated 24h | 1129.69 | 76 |
GSM687729 | Patient 452 treated 24h | 1182.05 | 78 |
GSM687727 | Patient 451 treated 4 weeks | 649.284 | 67 |
GSM687731 | Patient 452 treated 4 weeks | 1648.69 | 81 |